MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • MDS Virtual Congress 2021

    Subclinical inflammation and Parkinson’s disease

    G. Pagano (Basel, Switzerland)

    Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…
  • MDS Virtual Congress 2021

    Development of quantitative tools for in-home clinical assessment of people with Parkinson’s disease

    T. Virmani, L. Pillai, A. Glover, A. Kemp, J. Utecht, H. Spencer, T. Nolan, M. Rutherford, P. Farmer, S. Syed, H. Eswaran, M. Lotia, J. Bona, L. Larson-Prior, F. Prior (Little Rock, USA)

    Objective: To develop telehealth digital data collection methods for evaluation of multi-modal function in people with Parkinson’s Disease (PwPD) and develop biomedical informatics tools for…
  • MDS Virtual Congress 2021

    Qualitative Interviews With Children/Adolescents With Dyskinetic Cerebral Palsy (DCP) and Their Caregivers

    D. Claassen, H. Riordan, L. Dure, R. Battini, A. Cortez, M. Gordon, M. O’Connor, K. Jackson, A. Foster, M. Kosinski (Nashville, USA)

    Objective: To capture input from children/adolescents with DCP and their caregivers on the content validity of the Movement Disorders–Childhood Rating Scale (MD-CRS). Background: DCP is…
  • MDS Virtual Congress 2021

    Caregiving people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To show results form a study on caregiving PPD from a relational perspective. Background: Caregiving people with chronic neurological diseases like PPD can lead…
  • MDS Virtual Congress 2021

    Translation and validation of two Parkinson’s disease specific burden questionnaires from German into French.

    S. Bayen, J. Heutte, J-C. Vanderbecken, C. Moreau, L. Defebvre, W. Messaadi, D. Devos, N. Messaadi (Lille, France)

    Objective: The study purpose was to translate the questionnaires and to evaluate their internal consistency and temporal stability in a French study population, composed of…
  • MDS Virtual Congress 2021

    Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

    H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)

    Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…
  • MDS Virtual Congress 2021

    The impact of gender identity and gender role orientation on health-related quality of life in people with Parkinson’s disease.

    I. Göttgens, S. Darweesh, B. Bloem, S. Oertelt-Prigione (Nijmegen, Netherlands)

    Objective: To assess the associations of gender identity and gender role orientation with health-related quality of life (HRQoL) among persons with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To investigate satisfaction with daily remote monitoring with a digital health technology tool (DHTT) in individuals with early Parkinson’s disease (PD) and the relationship…
  • MDS Virtual Congress 2021

    Emergence of new symptoms in experiences of daily living in early Parkinson’s disease

    J. Cedarbaum, M. Tosin, T. Simuni, G. Stebbins (Woodbridge, USA)

    Objective: To explore the utility of assessing emergence of new symptoms (ES) impacting the daily experiences of patients with early Parkinson’s disease (PD) in relation…
  • MDS Virtual Congress 2021

    The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To examine the experience profile of PD Diary raters in clinical trials Background: The Parkinson’s Disease (PD) Home Diary (Hauser, 2000)1 is a widely…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley